Published online before print December 12, 2005, doi: 10.1161/CIRCULATIONAHA.105.542266
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2005;112:3823-3832.)
© 2005 American Heart Association, Inc.
Arrhythmia/Electrophysiology |
Arrhythmogenic Right Ventricular Dysplasia
A United States Experience
From the Division of Cardiology (D.D., K.N., C.B., K.P., H.T., J.P., A.R., C.T., C.J., S.D.R., D.P.J., T.A., D.A.B., H.C.), Department of Radiology (D.A.B.), and Division of Pediatric Cardiology (P.J.S.), The Johns Hopkins University School of Medicine, Baltimore, Md.
Correspondence to Hugh Calkins, MD, 600 N Wolfe St, Carnegie 530, Baltimore, MD 21287. E-mail hcalkins{at}jhmi.edu
Received February 15, 2005; revision received October 13, 2005; accepted October 17, 2005.
Background— Arrhythmogenic right ventricular dysplasia (ARVD) is an inherited cardiomyopathy characterized by right ventricular dysfunction and ventricular arrhythmias. The purpose of our study was to describe the presentation, clinical features, survival, and natural history of ARVD in a large cohort of patients from the United States.
Methods and Results— The patient population included 100 ARVD patients (51 male; median age at presentation, 26 [interquartile range {IQR}, 18 to 38; range, 2 to 70] years). A familial pattern was observed in 32 patients. The most common presenting symptoms were palpitations, syncope, and sudden cardiac death (SCD) in 27%, 26%, and 23% of patients, respectively. Among those who were diagnosed while living (n=69), the median time between first presentation and diagnosis was 1 (range, 0 to 37) year. During a median follow-up of 6 (IQR, 2 to 13; range, 0 to 37) years, implantable cardioverter/defibrillators (ICD) were implanted in 47 patients, 29 of whom received an appropriate ICD discharge, including 3 patients who received the ICD for primary prevention. At follow-up, 66 patients were alive, of whom 44 had an ICD in place, 5 developed signs of heart failure, 2 had a heart transplant, and 18 were on drug therapy. Thirty-four patients died either at presentation (n=23: 21 SCD, 2 noncardiac deaths) or during follow-up (n=11: 10 SCD, 1 of biventricular heart failure), of whom only 3 were diagnosed while living and 1 had an ICD implanted. On Kaplan-Meier analysis, the median survival in the entire population was 60 years.
Conclusions— ARVD patients present between the second and fifth decades of life either with symptoms of palpitations and syncope associated with ventricular tachycardia or with SCD. Diagnosis is often delayed. Once diagnosed and treated with an ICD, mortality is low. There is a wide variation in presentation and course of ARVD patients, which can likely be explained by the genetic heterogeneity of the disease.
CLINICAL PERSPECTIVE
This article has been cited by other articles:
 |
|
 |
|
  C. M. Steger, T. Hager, H. Antretter, H. X. Hoyer, J. Altenberger, G. Polzl, L. Muller, and D. Hofer Cardiac sarcoidosis mimicking arrhythmogenic right ventricular dysplasia BMJ Case Reports, November 18, 2009; 2009(nov18_1): bcr0820092204 - bcr0820092204. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. D. den Haan, B. Y. Tan, M. N. Zikusoka, L. I. Llado, R. Jain, A. Daly, C. Tichnell, C. James, N. Amat-Alarcon, T. Abraham, et al. Comprehensive Desmosome Mutation Analysis in North Americans With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circ Cardiovasc Genet, October 1, 2009; 2(5): 428 - 435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Jain, D. Dalal, A. Daly, C. Tichnell, C. James, A. Evenson, R. Jain, T. Abraham, B. Y. Tan, H. Tandri, et al. Electrocardiographic Features of Arrhythmogenic Right Ventricular Dysplasia Circulation, August 11, 2009; 120(6): 477 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. F. Tops, K. Prakasa, H. Tandri, D. Dalal, R. Jain, V. L. Dimaano, D. Dombroski, C. James, C. Tichnell, A. Daly, et al. Prevalence and pathophysiologic attributes of ventricular dyssynchrony in arrhythmogenic right ventricular dysplasia/cardiomyopathy. J. Am. Coll. Cardiol., July 28, 2009; 54(5): 445 - 451. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R M Campbell, S Berger, and J Drezner Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation Br. J. Sports Med., May 1, 2009; 43(5): 336 - 341. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, H. Tandri, D. P. Judge, N. Amat, R. Macedo, R. Jain, C. Tichnell, A. Daly, C. James, S. D. Russell, et al. Morphologic Variants of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy: A Genetics-Magnetic Resonance Imaging Correlation Study J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1289 - 1299. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Groenink and A. A.M. Wilde The "Accordion Sign," a New Tune in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Magnetic Resonance Imaging? J. Am. Coll. Cardiol., April 14, 2009; 53(15): 1300 - 1301. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Shephard and C. Semsarian Advances in the prevention of sudden cardiac death in the young Therapeutic Advances in Cardiovascular Disease, April 1, 2009; 3(2): 145 - 155. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Asimaki, H. Tandri, H. Huang, M. K. Halushka, S. Gautam, C. Basso, G. Thiene, A. Tsatsopoulou, N. Protonotarios, W. J. McKenna, et al. A New Diagnostic Test for Arrhythmogenic Right Ventricular Cardiomyopathy N. Engl. J. Med., March 12, 2009; 360(11): 1075 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Koplan and W. G. Stevenson Ventricular Tachycardia and Sudden Cardiac Death Mayo Clin. Proc., March 1, 2009; 84(3): 289 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Gilljam and C.-H. Bergh Right ventricular cardiomyopathy: timing of heart transplantation in Uhl's anomaly and arrythmogenic right ventricular cardiomyopathy Eur J Heart Fail, January 1, 2009; 11(1): 106 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Corrado, C. Basso, M. Schiavon, A. Pelliccia, and G. Thiene Pre-Participation Screening of Young Competitive Athletes for Prevention of Sudden Cardiac Death J. Am. Coll. Cardiol., December 9, 2008; 52(24): 1981 - 1989. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Cooper Jr Right from the heart: when should myocardial biopsy be performed for suspected arrhythmogenic right ventricular cardiomyopathy/dysplasia? Eur. Heart J., November 2, 2008; 29(22): 2705 - 2707. [Full Text] [PDF]
|
|
|
|
|
|
D. J. Callans Diagnosing Subtle Forms of Potentially Life-Threatening Diseases. J. Am. Coll. Cardiol., February 19, 2008; 51(7): 740 - 741. [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Dalal, C. James, R. Devanagondi, C. Tichnell, A. Tucker, K. Prakasa, P. J. Spevak, D. A. Bluemke, T. Abraham, S. D. Russell, et al. Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1416 - 1424. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.P. van Tintelen, M. M. Entius, Z. A. Bhuiyan, R. Jongbloed, A. C.P. Wiesfeld, A. A.M. Wilde, J. van der Smagt, L. G. Boven, M. M.A.M. Mannens, I. M. van Langen, et al. Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circulation, April 4, 2006; 113(13): 1650 - 1658. [Abstract] [Full Text] [PDF]
|
|